1996
DOI: 10.1038/ng0796-325
|View full text |Cite
|
Sign up to set email alerts
|

Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy

Abstract: Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3' untranslated region of a putative protein kinase (DMPK). To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice. Dmpk-/-mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM. Muscles from mature mice show variation in fibre size, increased fibre degeneration and fibrosis. Adult Dmpk-/-mice show ultrastructura… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
181
0

Year Published

1997
1997
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 321 publications
(190 citation statements)
references
References 66 publications
7
181
0
Order By: Relevance
“…While all these data are consistent with haploinsufficiency of the cAMP kinase, it is difficult to understand how such mild changes in protein levels could result in the dramatic clinical variability seen in myotonic dystrophy patients. Moreover, transgenic mice that have no functional DM kinase (homozygous recessive, complete loss of function) show only a mild, late onset muscle phenotype, and share few of the other symptoms of the human disease (37,38).…”
Section: Discussionmentioning
confidence: 99%
“…While all these data are consistent with haploinsufficiency of the cAMP kinase, it is difficult to understand how such mild changes in protein levels could result in the dramatic clinical variability seen in myotonic dystrophy patients. Moreover, transgenic mice that have no functional DM kinase (homozygous recessive, complete loss of function) show only a mild, late onset muscle phenotype, and share few of the other symptoms of the human disease (37,38).…”
Section: Discussionmentioning
confidence: 99%
“…Although symptoms in skeletal muscle function are most prominent, DM also causes defects in nonmuscle cell types. The disease has been linked to a CTG triplet expansion in the 3'-untranslated exon of DM-kinase (Brook et al 1992;Fu et al 1992;Mahadevan et al 1992); but despite recent advances with mouse models (Jansen et al 1996;Reddy et al 1996), the substrate of DM-kinase and the pathway in which DM-kinase func tions are unknown. Based on the sequence similarities between human DM-kinase, C. elegans LET-502, and the other members of this kinase family shown in Figure 3, we propose that DM-kinase may act in a pathway similar to that shown in Figure 7, to influence cytoskeletal organization and cell shape.…”
Section: Possible Implications For Human Myotonic Dystrophymentioning
confidence: 99%
“…Importantly, the expression of MKBP/HSPB2, but not other sHSPs, is specifically up-regulated in the skeletal muscle of myotonic dystrophy patients as if to compensate for the reduced amount of DMPK. Together with the fact that DMPK knock-out mice develop a late-onset, progressive myopathy (25), these findings led us to propose that this kinase is involved in a stressresponse system in muscle cells by being a specific target of MKBP/HSPB2 (23). Furthermore, because MKBP/HSPB2 itself is localized not only at the neuromuscular junction where DMPK is concentrated, but also at the Z-band of myofibrils, we speculated that MKBP/HSPB2 also contributes to the maintenance of myofibril integrity by interacting directly with myofibrils independent of DMPK.…”
mentioning
confidence: 99%